Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

London

London Lab Live

London Lab Live is the UK’s most exciting and inclusive event focused on the future of laboratories. It brings together innovators, start-ups, and industry leaders [...]

London

Advanced Therapies Congress

Europe's largest cell and gene therapy conference and exhibition brings together senior leaders from pioneering ATMP companies, exploring the latest technologies and strategies shaping the [...]

Go to Top